[1. Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulmonary Medicine. 2020;10. Available from: doi: 10.1155/2020/6175964.10.1155/2020/6175964743916032850151]Search in Google Scholar
[2. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5): 401–409.10.1136/thx.2004.030205175890515860716]Search in Google Scholar
[3. NHS England. Aftercare needs of inpatients recovering from COVID-19. Jun 2020. Available from: https://www.england.nhs.uk/coronavirus/publication/after-care-needs-of-inpatients-recoveringfrom-covid-19.]Search in Google Scholar
[4. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Research. 2020;8: 8.10.1038/s41413-020-0084-5701871732128276]Search in Google Scholar
[5. Chen J, Wu J, Hao S, Yang M, Lu X, Chen X, et al. Long term outcomes in survivors of epidemic influenza A (H7N9) virus infection. Scientific Reports. 2017;7: 17275.10.1038/s41598-017-17497-6572286129222500]Search in Google Scholar
[6. Zuo W, Zhao X, Chen YG. SARS Coronavirus and lung fibrosis. Molecular biology of the SARS-Coronavirus. 2009;247–258. Published 2009 Jul 22. Available from: doi: 10.1007/978-3-642-03683-5_15.10.1007/978-3-642-03683-5_15]Search in Google Scholar
[7. Ioshi A. Long term complications associated with Covid-19: a review. International Journal of Innovative Science and Research Technology 2020;5(9): 324–326.10.38124/IJISRT20SEP144]Search in Google Scholar
[8. TOI STAFF-(Akiko Iwasaki, a professor of immunobiology at Yale interview)- ‘Long COVID’ may be caused by body attacking itself, not the virus – study-14 December 2020, The Times from Israel.]Search in Google Scholar
[9. Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC. Novel insights on the pulmonary vascular consequences of COVID-19. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2020;319(2): L277–L288.10.1152/ajplung.00195.2020741423732551862]Search in Google Scholar
[10. Geddes L. Why strange and debilitating coronavirus symptoms can last for months. Scientist 2020. Available from: https://www.newscientist.com/article/mg24632881-400-why-strange-and-debilitatingcoronavirus-symptoms-can-last-for-months/.]Search in Google Scholar
[11. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. European Journal of Radiology. 2020;127: 109009. Available from: doi: 10.1016/j. ejrad.2020.10900 910.1016/j.ejrad.2020.109009]Search in Google Scholar
[12. COVID Symptom Study. How long does COVID-19 last? Kings College London; 2020. Available from https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI-.]Search in Google Scholar
[13. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Modern Pathology. 2020. Available from: doi: 10.1038/s41379-020-0536-x.10.1038/s41379-020-0536-x715623132291399]Search in Google Scholar
[14. Marchiori E, Hochhegger B, Zanetti G. Organising pneumonia as a late abnormality in influenza A (H1N1) virus infection. The British Journal of Radiology. 2012;85: 841; author reply 842.10.1259/bjr/91363092347412622665929]Search in Google Scholar
[15. Ong K-C, Ng AW-K, Lee LS-U, Kaw G, Kwek S-K, Leow MK-S, et al. 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest. 2005;128: 1393–1400.10.1378/chest.128.3.1393709473916162734]Search in Google Scholar
[16. Kreuter M, Polke M, Walsh SL, Krisam J, Collard HR, Chaudhuri N, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonization. European Respiratory Journal. 2020;55(4): 1901760.10.1183/13993003.01760-2019]Search in Google Scholar
[17. Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. Journal of Medical Virology. 2020. Available from: doi: 10.1002/jmv.25822.10.1002/jmv.25822]Search in Google Scholar
[18. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory Research. 2020;21: 163. Available from: doi: 10.1186/s12931-020-01429-6.10.1186/s12931-020-01429-6]Search in Google Scholar
[19. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4): 2247–2261.10.1378/chest.128.4.2247]Search in Google Scholar
[20. Zheng Z, Chen R, Wu H, Liu X, He W, Xu Y, et al. Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005;17(6): 329.]Search in Google Scholar
[21. NGAI JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3): 543–550.10.1111/j.1440-1843.2010.01720.x]Search in Google Scholar
[22. Zhao YM, Shang YM, Song WB, Li Q-Q, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. E ClinicalMedicine. 2020;25: 100463. Available from: doi: 10.1016/j.eclinm.2020.100463.10.1016/j.eclinm.2020.100463]Search in Google Scholar
[23. Ahmed H, Patel K, Greenwood D, Halpin St., Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis of follow-up studies. medRxiv. 2020.04.16.20067975; Available from: doi: 10.1101/2020.04.16.20067975.10.1101/2020.04.16.20067975]Search in Google Scholar
[24. Cardinal-Fernández P, Lorente JA, Ballén-Barragán A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Annals of the American Thoracic Society. 2017;14: 844–850.10.1513/AnnalsATS.201609-728PS]Search in Google Scholar
[25. Kumar Rai D, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis- Is it reversible? Indian Journal of Tuberculosis, 2020, Available from: doi: 10.1016/j.ijtb.2020.11.003. Available from: http://www.sciencedirect.com/science/article/pii/S0019570720302134.]Search in Google Scholar
[26. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respiratory Medicine. 2020;8(8): 750–752.10.1016/S2213-2600(20)30222-8]Search in Google Scholar
[27. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerging Microbes & Infections. 2020;9(1): 2190–2199.10.1080/22221751.2020.1825914758644632940572]Search in Google Scholar
[28. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6): 603–605.10.1001/jama.2020.12603734909632644129]Search in Google Scholar
[29. Tenforde MW, Kim SS, Lindsell CJ, Rose EB., Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020;69: 993–998.10.15585/mmwr.mm6930e1739239332730238]Search in Google Scholar
[30. Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term Follow-up. Archives of Internal Medicine. 2009;169(22): 2142–2147.10.1001/archinternmed.2009.38420008700]Search in Google Scholar
[31. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Rodriguez-Morales Coronavirus Disease 2019–COVID-19. Available from: doi: 10.1128/CMR.00028-20.10.1128/CMR.00028-20740583632580969]Search in Google Scholar
[32. Fraser E. Long term respiratory complications of covid-19. BMJ. 2020;370: m3001. Available from: doi: 10.1136/bmj.m3001 (Published 03 August 2020.10.1136/bmj.m300132747332]Search in Google Scholar
[33. Assaf G, Davis H, McCorkell L, Wei H, Brooke O, Akrami A, et al. An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient Led Research, 2020. Available from: https://patientresearchcovid19.com/.]Search in Google Scholar
[34. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews. 2017;4: PMID: 28444695.10.1002/14651858.CD003200.pub7641952428444695]Search in Google Scholar
[35. Trisha G, Matthew K, Christine A’C, Maria B, Laiba H. Management of post-acute covid-19 in primary care. BMJ. 2020;370: m3026.10.1136/bmj.m302632784198]Search in Google Scholar
[36. Homerton University Hospital. Post COVID-19 patient information pack. 2020. Available from: https://www.hackneycitizen.co.uk/wp-content/uploads/Post-COVID-19-information-pack5.pdf.]Search in Google Scholar
[37. O’Driscoll BR, Howard LS, Earis J, Mak V; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1): ii1-90.10.1136/thoraxjnl-2016-20972928507176]Search in Google Scholar
[38. National Institute for Health and Care Excellence. Statement about graded exercise therapy in the context of COVID-19. In: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (in development GID-NG10091). 2020. Available from: http://www.nice.org.uk/guidance/gid-ng10091/documents/statement.]Search in Google Scholar
[39. Hoffman GJ, Webster NJ, Bynum JPW. A framework for aging-friendly services and supports in the age of COVID-19. Journal of Aging & Social Policy. 2020;32: 450–459.10.1080/08959420.2020.177123932441572]Search in Google Scholar
[40. Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. 2020;17(11): 1984–1990. Available from: doi: 10.1016/J. HRTHM.2020.06.0 26.]Search in Google Scholar
[41. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation. 2009;39(7): 618–625. Available from: doi: 10.1111/j.1365-2362.2009.02153.x.10.1111/j.1365-2362.2009.02153.x716376619453650]Search in Google Scholar
[42. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging (MRI) in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11): 1265–1273.10.1001/jamacardio.2020.3557]Search in Google Scholar
[43. Yancy CW, Fonarow GC. Coronavirus disease 2019 (COVID-19) and the heart – is heart failure the next chapter? JAMA Cardiology. 2020;5(11): 1216–1217.10.1001/jamacardio.2020.3575]Search in Google Scholar
[44. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7): 811–818.10.1001/jamacardio.2020.1017]Search in Google Scholar
[45. Chang J-J, Lin M-S, Chen T-H, Chen D-Y, Chen S-W, Hsu J-T, et al. Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment – a Nationwide Cohort Study. International Journal of Medical Sciences. 2017;14: 1241–1250.10.7150/ijms.20618]Search in Google Scholar
[46. Mitrani RD, Abas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17: 1984–1990.10.1016/j.hrthm.2020.06.026]Search in Google Scholar
[47. Andrejak C, Cottin V, Crestani B, Debieuvre D, Bermejo J-G, Panzini CM, et al. Guide de prise en charge des séquelles respiratoires post infection à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de Pneumologie de Langue Francaise. Version du 10 novembre 2020. Revue des Maladies Respiratoires. 2020, Available from: doi: 10.1016/j. rmr.2020.11.009.10.1016/j.rmr.2020.11.009]Search in Google Scholar
[48. Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, et al. Effect of dexamethasone in hospitalized patients with covid-19: preliminary report. MedRxiv 20202020.2006.2022.20137273 [Preprint]. Available from: https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.]Search in Google Scholar
[49. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine. 2020;8(8): P507–P515. Available from: doi: 10.1016/S2213-2600(20)30225-3.10.1016/S2213-2600(20)30225-3]Search in Google Scholar
[50. British Thoracic Society. Guidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia. 2020. Available from: www.brit-thoracic.org.uk.]Search in Google Scholar
[51. del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17): 1723–1724.10.1001/jama.2020.19719]Search in Google Scholar
[52. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infectious Diseases. 2020;20(10): 1115–1117.10.1016/S1473-3099(20)30701-5]Search in Google Scholar